APA
CLVS

American Portfolios Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

American Portfolios Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$480 – 3334
2020
Q4 		$480 Hold
100
– – ﹤0.01% 2906
2020
Q3 		$583 Hold
100
– – ﹤0.01% 2828
2020
Q2 		$675 Sell
100
-200
-67% -$1.51K ﹤0.01% 2733
2020
Q1 		$1.91K Buy
300
+200
+200% +$1.6K ﹤0.01% 2416
2019
Q4 		$1.04K Buy
+100
New +$727 ﹤0.01% 2687

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

American Portfolios Advisors's CLVS Position: Q1 2021 in Review

American Portfolios Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 100 shares — an estimated $480 sold.

American Portfolios Advisors first reported a position in CLVS in Q4 2019 and held it in 5 quarters. The position peaked at $1.91K in Q1 2020. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

  • American Portfolios Advisors reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 100 Clovis Oncology, Inc. shares in Q1 2021, an estimated $480.
  • American Portfolios Advisors first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 5 quarters.
  • American Portfolios Advisors's Clovis Oncology, Inc. position peaked at $1.91K in Q1 2020.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.